Immunosuppressive drugs: Beyond glucocorticoids

Veterinary Medicine

Volumn 105, Issue 8, 2010, Pages 364-371

  Pressler, Barrak ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955891438     PISSN: 87507943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. l. Cines DB, McKenzte SE, Siegel DL. Mechanisms of action of therapeutics in idiopathic thrombocytopenic purpura. J Pediatr Hemotol Oncol 2003;25 Suppl 1: S52-S56. (Pubitemid 37517920)
2. Sathasivam S. Steroids and immunosuppressant drugs in myasthenia gravis. Nat Clin Pract Neurol 2008;4(6):317-327. (Pubitemid 351803614)
3. Piek CJ, Junius G, Dekker A, et al. Idiopathic immunemediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs. J Vet Intern Med 2008;22(2):366-373. (Pubitemid 351570502)
4. Reimer ME, Troy GC, Warnick LD. Immune-mediated hemolytic anemia: 70 cases (1988-1996). J Am Anim Hosp Assoc 1999;35(5):384-391. (Pubitemid 29428640)
5. Weinkle TK, Center SA, Randolph JF, et al. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002). J Am Vet Med Assoc 2005;226(11):1869- 1880. (Pubitemid 40746063)
6. Goggs R, Boag AK, Chan DL. Concurrent immune-mediated haemolytic anaemia and severe thrombocytopenia in 21 dogs. Vet Rec 2008;163(11):323-327.
7. Palmeiro BS, Morris DO, Goldschmidt MH, et al. Cutaneous reactive histiocytosis in dogs: a retrospective evaluation of 32 cases. Vet Dermatol 2007;18(5):332-340. (Pubitemid 47397829)
8. Vargo CL, Taylor SM, Haines DM. Immune mediated neutropenia and thrombocytopenia in 3 giant schnauzers. Can Vet J 2007;48(11):1159-1163. (Pubitemid 350226265)
9. Olivry T, Bergvall KE, Atlee BA. Prolonged remission after immunosuppressive therapy in six dogs with pemphigus foliaceus. Vet Dermatol 2004;15(4):245-252. (Pubitemid 39178289)
10. Rosenkrantz WS. Pemphigus: current therapy. Vet Dermatol 2004;15(2):90-98. (Pubitemid 38482373)
11. Favrot C, Reichmuth P, Olivry T. Treatment of canine atopic dermatitis with azathioprine: a pilot study. Vet Rec 2007;160(15):520-521. (Pubitemid 46663552)
12. Harkin KR, Phillips D, Wilkerson M. Evaluation of azathioprine on lesion severity and lymphocyte blastogenesis in dogs with perianal fistulas. J Am Anim Hosp Assoc 2007;43 (1) 21-26. (Pubitemid 46403537)
13. Dewey CW, Coates JR, Ducote JM, et al. Azathioprine therapy for acquired myasthenia gravis in five dogs. J Am Anim Hosp Assoc 1999;35(5):396-402 (Pubitemid 29428642)
14. Rinkardt NE, Kruth SA. Azathioprine-induced bone marrow toxicity in four dogs. Cm Vet J 1996;37(10):612-613. (Pubitemid 26366056)
15. Salavaggione OE, Kidd L, Prondzinski JL, et al. Canine red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics. Pharmacogenetics 2002;12(9):713-724. (Pubitemid 36054938)
16. Kidd LB, Salavaggione OE, Szumlanski CL, et al. Thiopurine methyltransferase activity in red blood cells of dogs. J Vet Intern Med 2004;18(2):214-218. (Pubitemid 38393632)
17. Salavaggione OE, Yang C, Kidd LB, et al. Cat red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics. J Pharmacol Exp Ther 2004;308(2):617-626. (Pubitemid 38134224)
18. Robson D. Review of the pharmacokinetics, interactions and adverse reactions of cyclosporine in people, dogs and cats. Vet Rec 2003;152(24):739- 748. (Pubitemid 36798928)
19. House AK, Guitian J, Gregory SP, et al. Evaluation of the effect of two dose rates of cyclosporine on the severity of perianal fistulae lesions and associated clinical signs in dogs. Vet Surg 2006;35(6):543-549. (Pubitemid 44154775)
20. Mathews KA, Sukhiani HR. Randomized controlled trial of cyclosporine for treatment of perianal fistulas in dogs. J Am Vet Med Assoc 1997;211(10):1249- 1253. (Pubitemid 27509407)
21. Mathews KA, Ayres SA, Tano CA, et al. Cyclosporin treatment of perianal fistulas in dogs. Can Vet J 1997;38(1):39-41. (Pubitemid 27076956)
22. Misseghers BS, Binnington AG, Mathews KA. Clinical observations of the treatment of canine perianal fistulas with topical tacrolimus in 10 dogs. Cm Vet J 2000;41(8):623-627.
23. Patricelli AJ, Hardie RJ, McAnulty JE. Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs. J Am Vet Med Assoc 2002;220(7):1009-1016. (Pubitemid 34260087)
24. Grundy SA, Barton C. Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989-1999). J Am Vet Med Assoc 2001;218(4):543-546.
25. Robson DC, Burton GG. Cyclosporin: applications in small animal dermatology. Vet Dermatol 2003;14(1):1-10.
26. Padrid P. CVT update: feline asthma. In: Bonagura JD, ed. Kirk's current veterinary therapy XIII: small animal practice. Philadelphia: WB Saunders Co, 2000;805-810.
27. Mehl ML, Kyles AE, Craigmill AL, et al. Disposition of cyclosporine after intravenous and multi-dose oral administration in ats. J Vet Pharmacol Ther 2003;26(5):349-354. (Pubitemid 37378511)
28. Schmiedt CW, Grimes JA, Holzman G, et al. Incidence and risk factors for development of malignant neoplasia after feline renal transplantation and cyclosporine-based immunosuppression. Vet Comp Oncol 2009;7(1):45-53.
29. Zwemer J, Fiorentino D. Mycophenolate mofetil. Dermatol Ther 2007;20(4):229-238. (Pubitemid 350029312)
30. Villarroel MC, Hidalgo M, Jimeno A. Mycophenolate mofetil: An update. Drags Today (Bare) 2009;45(7):521-532.
31. Ritter ML, Pirofski L. Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity. Transpl Inject Dis 2009;11(4):290-297.
32. Nielsen L, Niessen S, Ramsay M, et al. The use of mycophenolate mofetil in eight dogs with idiopathic immune mediated haemolytic anaemia [abstr], in Proceedings. Congress European Coll Vet Intern Med Companion Anim, 2005.
33. Yuki M, Sugimoto N, Otsuka H, et al. Recovery of a dog from aplastic anaemia after treatment with mycophenolate mofetil. Aust Vet J 2007;85(12):495-497. (Pubitemid 350196591)
34. Dewey CW, Boothe DM, Rinn KL, et al. Treatment of a myasthenic dog with mycophenolate mofetil. J Vet Emerg Crit Care 2000;10:177-187.
35. Banyard MRC, Hassett RS. The use of mycophenolate mofetil in the treatment of a case of immune-mediated glomerulonephritis in a dog. Aust Vet Pract 2001;31:103-106. (Pubitemid 33659757)
36. Dewey CW, Cerda-Gonzalez S, Fletcher DJ, et al. Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired myasthenia gravis: 27 cases (1999-2008). J Am Vet Med Assoc 2010;236(6):664-668.
37. Lupu M, McCune JS, Kuhr CS, et al. Pharmacokinetics of oral mycophenolate mofetil in dog: bioavailability studies and the impact of antibiotic therapy. Bid Blood Marrow Transplant 2006;12(12):1352-1354. (Pubitemid 44858259)
38. Chanda SM, Sellin JH, Torres CM et al. Comparative gastrointestinal effects of mycophenolate mofetil capsules and enteric-coated tablets of sodium-mycophenolic acid in beagle dogs. Traniplant Proc 2002;34(8):3387-3392. (Pubitemid 35463352)
39. Marder W, McCune WJ. Advances in immunosuppressive therapy. Semin Respir Crit Care Med 2007;28(4):398-417. (Pubitemid 350194723)
40. Pinto P, Dougados M. Leflunomide in clinical practice. Acta Reumatol Port 2006;31(3):215-224
41. Tallantyre E, Evangelou N, Constantinescu CS. Spotlight on teriflunomide. Int MS J 2008;15(2):62-68.
42. Williams CR, Sykes JE, Mehl M, et al. In vitro effects of the active metabolite of leflunomide, A77 1726, on feline herpesvirus-1. Am J Vet Res 2007;68(9):1010-1015. (Pubitemid 47408331)
43. Hanna FY. Disease modifying treatment for feline rheumatoid arthritis. Vet Comp Orthop Traumatol 2005;18(2):94-99. (Pubitemid 40814258)
44. Colopy SA, Baker TA, Muir P. Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006-2008). J Am Vet Med Assoc 2010;236(3):312-318.
45. Gregory CR, Stewart A, Sturges B, et al. Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy. Transplant Proc 1998;30(8):4143-4148. (Pubitemid 29013187)
46. Bianco D, Hardy RM. Treatment of Evans' syndrome with human intravenous immunoglobulin and leflunomide in a diabetic dog. J Am Anim Hosp Assoc 2009;45(3):147-150.
47. Mason N, Duval D, Shofer FS, et al. Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune-mediated hemolytic anemia in dogs: a randomized controlled clinical trial. J Vet Intern Med 2003;17(2):206-212. (Pubitemid 37465356)
48. Burgess K, Moore A, Rand W, et al. Treatment of immunemediated hemolytic anemia in dogs with cyclophosphamide. J Vet Intern Med 2000;14(4):456-462.
49. Willard MD. Feline inflammatory bowel disease: a review. J Feline Med Sury 1999;1(3):155-164. (Pubitemid 129669629)
50. Allenspach K, Rufenacht S, Sauter S, et al. Pharmacokinetics and clinical efficacy of cyclosporine treatment of dogs with steroid-refractory inflammatory bowel disease. J Vet Intern Med 2006;20(2):239-244.